Check your medicine cabinet NOW: Safety alert over common headache medication which contains a dangerous banned sedative
- Warning issued for EVE-branded tablets
- Contain hypnotic sedative apronal
- Not registered for use or sale in Australia
Australia’s medicine and therapeutic regulator has issued an urgent warning about a common headache medication which contains a dangerous sedative which poses a significant health risk.
The Therapeutic Goods Administration (TGA) has put out a safety alert for EVE-branded tablets containing allylisopropylacetylurea, also known as apronal.
The hypnotic sedative has been found in a range of imported products, including EVE Quick for Headache, EVE Quick for Headache DX EVE, EVE A and EVE A EX.
The products are banned from sale, supply and use in Australia.
The Therapeutic Goods Administration issued warnings about headache medications containing apronal (stock image)
‘We are warning consumers against taking EVE branded products that contain allylisopropylacetylurea as they pose a significant health risk and are prohibited from sale, supply or use in Australia,’ the TGA alert states.
‘Apronal is a hypnotic sedative that was withdrawn from clinical use in Australia due to dangerous side effects and is banned in most countries in the world.’
‘If you or someone you care for is taking any of these products, stop immediately and take any remaining tablets to your local pharmacy for safe disposal.’
Apronal also goes by the names of apronalide, ACE and (2-Isopropyl-4-pentenoyl) urea.
Synthesized in 1926 by Hoffmann-La Roche, apronal is no longer used except in Japan.
Consumers and businesses are reminded that it’s illegal to import, advertise or supply unregistered therapeutic goods in Australia, including EVE or any brand of apronal products.
A safety alert was been issued for imported EVE-branded tablets, including EVE A EX
The illegal importation and supply of these products may result in massive fines or court action.
Consumers are also warned to use exercise extreme caution when buying medicines from unknown overseas websites as they may contain undisclosed and potentially harmful ingredients.
They may also not meet the same standards of quality, safety and efficacy as those approved in Australia.
